StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
086710.KQ$7830.00-2.37%
Fair $7830.00+0.0%

086710.KQ

Sunjin Beauty Science Co.Ltd

Unknown / UnknownKOSDAQ

$7830.00

-190.00 (-2.37%)

Fairly Valued+0.0%Fair Value $7830.00Fund rank 25/100 · Data gapFallback financials|
SA 26/D
F-Score: 4/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 22%

FCF escenarios

weak_data · normalized FCF $-10.4B · quality 61.0/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 32/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

26/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 086710.KQLocal privado en este navegador · Sunjin Beauty Science Co.Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$94.0B

P/E

15.8x

↑

EV/EBITDA

9.5x

↑

ROE

7.0%

↑

Gross Margin

39.4%

↑

Debt/Equity

0.81

↑
52-Week Range$7830
$7500$14660

TradingView lightweight chart

086710.KQ price, volumen y niveles de valoración

Último $7,830Periodo -47.6%
Fair value: $7,830

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.9%

FCF CAGR

—

FCF margin

-11.1%

FCF / Net income

-1.50x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $80.77B · net income $5.96B · FCF $-8.95B

2022-FY → 2025-FY

Gross margin

39.4%+7.9% pts

Operating margin

7.5%-0.8% pts

Net margin

7.4%-23.1% pts

FCF margin

-11.1%-1.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$80.77B$80.77B$79.37B$72.62B$64.33B
Net Income$5.96B$5.96B$9.12B$5.61B$19.63B
EBITDA$15.69B$15.69B$18.94B$14.39B$30.87B
EPS496.00496.00759.00467.001620.00
Gross Margin39.4%39.4%35.6%33.7%31.5%
Operating Margin7.5%7.5%13.4%12.5%8.3%
Net Margin7.4%7.4%11.5%7.7%30.5%
Balance Sheet
Debt/Equity0.810.810.710.590.79
Cash Flow
Free Cash Flow$-8.95B$-8.95B$-12.91B$-10.37B$-6.39B
Returns
ROE7.0%7.0%11.6%8.0%30.4%
Valuation
P/E15.7915.7912.4418.014.30
EV/EBITDA9.559.558.379.204.04
P/B1.111.111.441.451.31
Growth & Yield
Revenue Growth1.8%1.8%9.3%12.9%—
EPS Growth-34.7%-34.7%62.5%-71.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

11.9%

razonable

EPS terminal req.

$694.78

Spread vs growth

-46.5%

5Y implied EPS CAGR

11.1%

razonable

EPS terminal req.

$840.69

Spread vs growth

-45.8%

10Y implied EPS CAGR

10.6%

razonable

EPS terminal req.

$1353.93

Spread vs growth

-45.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -41.0%

Total return

-41.0%

Start / end P/E

17.5x → 15.8x

EPS bridge

759.00 → 496.00

Residual

+3.3%

EPS growth-34.7%
Multiple rerating-9.6%
Dividend+0.0%
Residual / FX / buybacks / cross-term+3.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.